<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-VREUOU4E</identifier><date>2011</date><creator>Plebani, Mario</creator><creator>Zambon, Carlo Federico</creator><relation>documents/doc/V/URN_NBN_SI_doc-VREUOU4E_001.htm</relation><relation>documents/doc/V/URN_NBN_SI_doc-VREUOU4E_001.pdf</relation><relation>documents/doc/V/URN_NBN_SI_doc-VREUOU4E_001.txt</relation><format format_type="issue">2</format><format format_type="volume">62</format><format format_type="type">article</format><format format_type="extent">str. 57</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">262560512</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-VREUOU4E</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">farmakogenomika</subject><title>from bench to beside</title><title>Pharmacogenetics</title></Record>